OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024
October 29, 2024 16:05 ET
|
OPKO Health, Inc.
MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2024 after the close of the...
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
October 07, 2024 08:00 ET
|
OPKO Health, Inc.
Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executedDevelopment...
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
September 23, 2024 08:00 ET
|
OPKO Health, Inc.
WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief...
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
August 07, 2024 16:06 ET
|
OPKO Health, Inc.
MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2024. Highlights from the...
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
August 01, 2024 16:05 ET
|
OPKO Health, Inc.
MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S....
OPKO Health Announces $100 Million Share Repurchase Program
July 18, 2024 08:00 ET
|
OPKO Health, Inc.
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's...
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
July 17, 2024 16:14 ET
|
OPKO Health, Inc.
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by...
OPKO Health to Participate in the Jefferies Global Healthcare Conference
May 31, 2024 10:48 ET
|
OPKO Health, Inc.
MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024...
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
May 07, 2024 16:05 ET
|
OPKO Health, Inc.
MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business...
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
May 03, 2024 08:00 ET
|
OPKO Health, Inc.
MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S....